The Public Health Impact of the Rx-to-OTC Switch of Triptan in Germany: Systematic Review and Framework Analysis
{{output}}
Introduction: Migraine is a prevalent and debilitating condition in Germany, affecting 10-15% of the population. Triptans are the primary treatment for acute attacks. The switch of triptans from prescription (Rx) to over-the-coun... ...
